MRD Monitoring in Acute Lymphoblastic Leukemia
0 Görünümler
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Daha fazla göster
Facebook Yorumları
Hiçbir yorum bulunamadı